Drawing for NEPHROLOGY CARE ALLIANCE

USPTO serial 88623891

NEPHROLOGY CARE ALLIANCE

Reviewed by CopyMark Law Group

Reg. 6548266Status 700Renewal
Filing date
Status date
Registration date
Nov 2, 2021
Examiner
HELMERS, SARA A
Law office
TMO LAW OFFICE 130

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NEPHROLOGY CARE ALLIANCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miriam D. Trudell

Miriam D. Trudell Davis Graham & Stubbs LLC3400 Walnut Street, Suite 700Denver, CO 80205United States

Goods and services

ClassDescriptionStatusFirst use
041Educational services, namely, conducting roundtables, seminars, conferences, and workshops in the field of kidney disease and kidney health and distribution of training materials in connection therewith for nephrologists and physicians in the primary field of treating patients with kidney disease and preventing the progression of chronic kidney disease (CKD); arranging and conducting educational roundtables and conferences for nephrologists and physicians in the primary field of treating patients with kidney disease and preventing the progression of chronic kidney disease (CKD); educational services, namely, conducting roundtables, seminars, conferences, and workshops in the field of kidney disease and kidney health for nephrologists and physicians in the primary field of treating patients with kidney disease and preventing the progression of chronic kidney disease (CKD); educational services, namely, training physicians in the field of treatment for kidney disease and kidney health patients; educational services, namely, conducting physician and staff training programs in the fields of diagnostic and interventional nephrology; educational services, namely, hosting educational roundtables, conferences, and seminars in the field of kidney disease and kidney health and dialysis for nephrologists and physicians in the primary field of treating patients with kidney disease and preventing the progression of chronic kidney disease (CKD); development of print, video, and online educational materials in the field of treatment of kidney disease and kidney health for nephrologists and physicians in the primary field of treating patients with kidney disease and preventing the progression of chronic kidney disease (CKD); dissemination of printed, video, and online educational materials of others in the field of treatment of kidney disease and kidney health for nephrologists and physicians in the primary field of treating patients with kidney disease and preventing the progression of chronic kidney disease (CKD); business training in the field of nephrology health care practice management; business training in the field of value-based kidney disease and kidney health care; educational services, namely, development of patient education curriculum and associated printed, video, and online materials for use in the treatment of kidney disease and kidney health for nephrologists and physicians in the primary field of treating patients with kidney disease and preventing the progression of chronic kidney disease (CKD); publication of printed, video, and online materials for use in treatment of kidney disease and kidney health for nephrologists and physicians in the primary field of treating patients with kidney disease and preventing the progression of chronic kidney disease (CKD), namely, nephrology practice performance guidelines, nephrology patient education materials for use by nephrologists and physicians in the primary field of treating patients with kidney disease and preventing the progression of chronic kidney disease (CKD); providing a website featuring resources for nephrologists and physicians in the primary field of treating patients with kidney disease and preventing the progression of chronic kidney disease (CKD), namely, a website featuring primarily non-downloadable instructional videos, texts, and graphic works in the field of kidney disease and kidney health and also featuring non-downloadable software for storing and managing electronic health records (EHR) for kidney disease and kidney health patients and for predictive analytics for managing kidney disease and kidney health patient careACTIVEMar 10, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 3, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 12, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 14, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 14, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 14, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 10, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 10, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 10, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 10, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 10, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 10, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 2, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 1, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 30, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 23, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 22, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 22, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 2, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2021CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 27, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 17, 2021IUAFUSE AMENDMENT FILED—
May 17, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 17, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 22, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 22, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 2, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 15, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 12, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 11, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 18, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 18, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 18, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 18, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 18, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 18, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2019DOCKASSIGNED TO EXAMINER—
Sep 27, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 23, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance